Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial
2007

Improving Medication Timing in Parkinson's Disease

Sample size: 83 publication 10 minutes Evidence: moderate

Author Information

Author(s): Katherine A Grosset, Donald G Grosset

Primary Institution: Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK

Hypothesis

Does providing educational information about the continuous dopaminergic hypothesis improve medication adherence and motor control in Parkinson's disease patients?

Conclusion

Providing patients with extra information improves their timing adherence to medication, but does not significantly change motor scores.

Supporting Evidence

  • 43 patients were randomized to the active group and 40 to the control group.
  • Timing adherence improved by 13.4% in the active group post-intervention.
  • Motor scores did not change significantly between the two groups.

Takeaway

Teaching patients with Parkinson's disease about their medication can help them take it on time, which is important for their health.

Methodology

Patients were randomized into an active group receiving educational intervention and a control group with standard management, with medication adherence monitored using electronic pill bottles over 3 months.

Potential Biases

Potential bias due to dropouts and the variability in patient response to the intervention.

Limitations

A significant number of patients were unable or unwilling to use the electronic monitoring bottles, which may affect adherence data.

Participant Demographics

Patients with idiopathic Parkinson's disease, average age 61 years, with a mix of males and females.

Statistical Information

P-Value

0.002

Confidence Interval

5.1 to 21.7

Statistical Significance

p = 0.002

Digital Object Identifier (DOI)

10.1186/1471-2377-7-20

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication